Avoiding Biopsy in Men With PI-RADS Scores 1 and 2 on Multiparametric MRI of the Prostate, Ready for Prime Time?

BJU International - United Kingdom
doi 10.1111/bju.14901
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Wiley

Related search

The Primacy of Multiparametric MRI in Men With Suspected Prostate Cancer

European Radiology
MedicineNuclear MedicineRadiologyImaging
2019English

Multiparametric MRI in Biopsy Guidance for Prostate Cancer: Fusion-Guided

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Pd28-10 Multiparametric-Mri Prior to Repeat Biopsy for Active Surveillance Can Identify Men With High-Risk Prostate Cancer

Journal of Urology
Urology
2017English

Stereotactic Body Radiotherapy for Prostate Cancer: Ready for Prime Time?

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

Prediction of Significant Prostate Cancer in Biopsy-Naïve Men: Validation of a Novel Risk Model Combining MRI and Clinical Parameters and Comparison to an ERSPC Risk Calculator and PI-RADS

PLoS ONE
Multidisciplinary
2019English

Correction To: Correlation of 3T Multiparametric Prostate MRI Using Prostate Imaging Reporting and Data System (PIRADS) Version 2 With Biopsy as Reference Standard

Abdominal Radiology
Nuclear MedicineRadiologyUrologyUltrasound TechnologyGastroenterologyRadiologicalImaging
2019English

Multiparametric MRI in Prostate Cancer and the NHS

Trends in Urology & Men's Health
2019English

Reliability of Negative Multiparametric MRI of the Prostate: Can We Avoid the Biopsy? Not Yet!

BJU International
Urology
2017English

The CHALICE Rule: Ready for Prime Time?

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy